Literature DB >> 6371180

Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity.

R L Rubin, R S Balderas, E M Tan, F J Dixon, A N Theofilopoulos.   

Abstract

We report that approximately 1/4 of monoclonal rheumatoid factors produced by hybridomas derived from fusions of spleen cells from MRL/lpr/lpr mice with systemic lupus erythematosus (SLE) and arthritis exhibited multiple reactivities with other autoantigens, including dDNA , histones, and/or cytoskeletal-cytoplasmic elements. The patterns of reactivities of most of these clones differed, indicating that each had a separate B cell ancestor. Studies with eluted antibodies demonstrated that a single species of antibody molecules was responsible for the observed multiple reactivities. Inhibition experiments suggested that an antibody combining site may be large enough to accommodate dissimilar epitopes. These findings may provide further insights into the generation and extent of antibody diversity as well as the etiopathogenesis of systemic autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6371180      PMCID: PMC2187302          DOI: 10.1084/jem.159.5.1429

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

1.  Purification of the five main calf thymus histone fractions by gel exclusion chromatography.

Authors:  E L Böhm; W N Strickland; M Strickland; B H Thwaits; D R van der Westhuizen; C von Holt
Journal:  FEBS Lett       Date:  1973-08-15       Impact factor: 4.124

2.  Certain rheumatoid factors react with nucleosomes.

Authors:  K Hannestad; B D Stollar
Journal:  Nature       Date:  1978-10-19       Impact factor: 49.962

Review 3.  On the specificity of antibodies.

Authors:  F F Richards; W H Konigsberg; R W Rosenstein; J M Varga
Journal:  Science       Date:  1975-01-17       Impact factor: 47.728

4.  Circulating anti-DNA-rheumatoid factor complexes in MRL/1 mice.

Authors:  S Izui; R A Eisenberg
Journal:  Clin Immunol Immunopathol       Date:  1980-03

5.  Evidence for multispecificity of antibody molecules.

Authors:  D J Cameron; B F Erlanger
Journal:  Nature       Date:  1977-08-25       Impact factor: 49.962

6.  A cross-reaction between beta2-microglobulin and kappa-light chains.

Authors:  A B Gottlieb; M Engelhard; H G Kunkel; N Tanigaki; D Pressman
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

7.  Polyclonal human antibodies to IgG (rheumatoid factors) which cross-react with cell nuclei.

Authors:  K Hannestad; A Johannessen
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

8.  IgM-rheumatoid factors cross-reactive with IgG and a cell nuclear antigen: apparent 'masking' in original serum.

Authors:  P M Johnson
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

9.  Characteristics of antinuclear antibodies in rheumatoid arthritis. Reactivity of rheumatoid factor with a histone-dependent nuclear antigen.

Authors:  C T Aitcheson; C Peebles; F Joslin; E M Tan
Journal:  Arthritis Rheum       Date:  1980-05

10.  Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype.

Authors:  V Agnello; A Arbetter; G Ibanez de Kasep; R Powell; E M Tan; F Joslin
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  25 in total

1.  Five groups of antigenic determinants on DNA identified by monoclonal antibodies from (NZB X NZW)F1 and MRL/Mp-lpr/lpr mice.

Authors:  A Morgan; R R Buchanan; A M Lew; I Olsen; N A Staines
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

Review 2.  Origins of anti-DNA autoantibodies.

Authors:  R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  Oligonucleotide linked to human gammaglobulin specifically diminishes anti-DNA antibody formation in cultured lymphoid cells from patients with systemic lupus erythematosus.

Authors:  Y Borel; H Borel
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Characterisation of non-histone nuclear proteins cross reactive with purified rheumatoid factors.

Authors:  J C Mason; P J Venables; P R Smith; R N Maini
Journal:  Ann Rheum Dis       Date:  1985-05       Impact factor: 19.103

5.  A monoclonal antibody to the surface membrane of human platelets which inhibits ristocetin- and collagen-induced platelet aggregation reacts with H1 histones of cell nuclei.

Authors:  L Cosgrove; F Alderuccio; B H Toh; J Pedersen; A Holliday; I McKenzie
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

6.  Multiple organ-reactivity of monoclonal autoantibodies to mouse erythrocytes.

Authors:  C Garzelli; F Basolo; C Puglisi; A Pacciardi
Journal:  Experientia       Date:  1987-08-15

7.  Human monoclonal antibodies from patients with rheumatoid arthritis: cross reactions against cellular constituents.

Authors:  D O Haskard; V Gul; A Morgan; P Kataaha; N A Staines; J R Archer
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

8.  Monoclonal human anti-DNA antibodies from EB virus-transformed lymphocytes of systemic lupus erythematosus (SLE) patients.

Authors:  T Sasaki; T Muryoi; Y Sekiguchi; E Tamate; K Yoshinaga; Y Kitagawa
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

9.  Human-human hybridoma autoantibodies with both anti-DNA and rheumatoid factor activities.

Authors:  J Rauch; H Tannenbaum; K Straaton; H Massicotte; J Wild
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

10.  Autoantibodies to nucleolin cross-react with histone H1 in systemic lupus erythematosus.

Authors:  W N Jarjour; S Minota; R A Roubey; T Mimura; J B Winfield
Journal:  Mol Biol Rep       Date:  1992-09       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.